A direct precursor to cellular energy, one step closer than earlier forms.
NAD⁺ is a coenzyme behind more than 500 enzymatic processes — including mitochondrial energy metabolism and the activation of sirtuin proteins.
Research indicates NAD⁺ levels tend to decline with age. NMN sits one metabolic step closer to NAD⁺ than earlier precursor forms, converting through established cellular pathways.†
Multiple randomized, placebo-controlled human trials have evaluated oral NMN supplementation and found it to be safe and well-tolerated, with associations including increased NAD⁺ levels in blood. A dose-dependent multicenter trial reported blood NAD⁺ increases with oral dosing evaluated up to 900 mg daily, alongside patient-reported and physical-performance measures. Additional trials in older adults have associated 250 mg/day with higher blood NAD⁺ and measures such as walking speed. Individual results may vary.†
References— Front. Nutrition, 2022 · Sci. Reports, 2023 · Endocrine J., 2020
NMN → NAD⁺ via NMNAT enzymes → supports sirtuin activation, PARP-related DNA maintenance, and mitochondrial energy metabolism.
† These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.